Pulmonary Hemodynamics and Ventilation in Patients With COVID-19-Related Respiratory Failure and ARDS.


Journal

Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 9 3 2021
medline: 29 5 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

It has been suggested that COVID-19-associated severe respiratory failure (CARDS) might differ from usual acute respiratory distress syndrome (ARDS) due to failing autoregulation of pulmonary vessels and higher shunt. We sought to investigate pulmonary hemodynamics and ventilation properties in patients with CARDS compared to patients with ARDS of pulmonary origin. This was a retrospective analysis of prospectively collected data from consecutive adults with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 patients treated in our ICU in 04/2020 and a comparison of the data to matched controls with ARDS due to respiratory infections treated in our ICU from 01/2014 to 08/2019 for whom pulmonary artery catheter data were available. CARDS patients (n = 10) had ventilation characteristics similar to those of ARDS (n = 10) patients. Nevertheless, mechanical power applied by ventilation was significantly higher in CARDS patients (23.4 ± 8.9 J/min) than in ARDS (15.9 ± 4.3 J/min; Respiratory failure in COVID-19 patients seems to differ only slightly from ARDS regarding ventilation characteristics and pulmonary hemodynamics. Our data indicate microcirculatory dysfunction. More data need to be collected to assure these findings and gain more pathophysiological insights into COVID-19 and respiratory failure.

Sections du résumé

BACKGROUND BACKGROUND
It has been suggested that COVID-19-associated severe respiratory failure (CARDS) might differ from usual acute respiratory distress syndrome (ARDS) due to failing autoregulation of pulmonary vessels and higher shunt. We sought to investigate pulmonary hemodynamics and ventilation properties in patients with CARDS compared to patients with ARDS of pulmonary origin.
METHODS METHODS
This was a retrospective analysis of prospectively collected data from consecutive adults with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 patients treated in our ICU in 04/2020 and a comparison of the data to matched controls with ARDS due to respiratory infections treated in our ICU from 01/2014 to 08/2019 for whom pulmonary artery catheter data were available.
RESULTS RESULTS
CARDS patients (n = 10) had ventilation characteristics similar to those of ARDS (n = 10) patients. Nevertheless, mechanical power applied by ventilation was significantly higher in CARDS patients (23.4 ± 8.9 J/min) than in ARDS (15.9 ± 4.3 J/min;
CONCLUSIONS CONCLUSIONS
Respiratory failure in COVID-19 patients seems to differ only slightly from ARDS regarding ventilation characteristics and pulmonary hemodynamics. Our data indicate microcirculatory dysfunction. More data need to be collected to assure these findings and gain more pathophysiological insights into COVID-19 and respiratory failure.

Identifiants

pubmed: 33678052
doi: 10.1177/0885066621995386
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

655-663

Auteurs

André Becker (A)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Frederik Seiler (F)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Ralf M Muellenbach (RM)

Department of Anaesthesiology and Critical Care, Campus Kassel of the University of Southampton, Kassel, Germany.

Guy Danziger (G)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Maren Kamphorst (M)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Christopher Lotz (C)

Department of Anaesthesiology and Critical Care Medicine, 9190University of Würzburg, Würzburg, Germany.

Robert Bals (R)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Philipp M Lepper (PM)

Department of Internal Medicine V-Pneumology, Allergology and Critical Care Medicine, 39072University Hospital of Saarland and Saarland University, Homburg/Saar, Germany.
Interdisciplinary COVID-19-Center, 39072University Hospital of Saarland, Saarland University, Homburg/Saar, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH